Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Linking choline metabolism to macrophage metabolic reprogramming

FY 2021-22

Summary
Choline is an essential nutrient that provides a critical precursor for membrane phospholipids, the neurotransmitter acetylcholine, and methyl groups for epigenetic regulation. In innate immune cells called macrophages, choline is needed for lipid homeostasis and proper inflammatory responses. When choline uptake and metabolism are blocked, both pro-and anti-inflammatory programs are dysregulated. In an in vitro model meant to mimic a pro-inflammatory environment, stimulation of macrophages with the bacterial cell membrane component lipopolysaccharide (LPS) causes a heightened pro-inflammatory response. We have evidence that this pro-inflammatory shift is accompanied by a dramatic shift toward glycolytic metabolism. Importantly, given the metabolic and phenotypic switch, an acute infection may be a context in which the inhibition of choline metabolism could benefit host survival. Current findings suggest that choline metabolism inhibition can skew the immune population in vivo. The drug RSM-932a (RSM) inhibits the first step in the metabolism of choline toward phospholipid and causes a significant increase in pro-inflammatory markers. These findings suggest that choline inhibition could help skew an in-vivo response that would increase survival during acute bacterial infection. This proposal aims to test the hypothesis that the inhibition of choline metabolism and the subsequent pro-inflammatory immune response will increase survival outcomes in models of acute bacterial infection. We hypothesize that choline inhibition affects pro-inflammatory outputs and markers by reprogramming metabolic energy pathways. The goals of this study are to uncover if and understand how the inhibition of choline metabolism can increase survival in the face of a bacterial challenge.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
467061
Name
Ilijevska Maja
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Linking choline metabolism to macrophage metabolic reprogramming
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Choline; Macrophage; Metabolism; Pro-Inflammatory
Abstract
Choline is an essential nutrient that provides a critical precursor for membrane phospholipids, the neurotransmitter acetylcholine, and methyl groups for epigenetic regulation. In innate immune cells called macrophages, choline is needed for lipid homeostasis and proper inflammatory responses. When choline uptake and metabolism are blocked, both pro-and anti-inflammatory programs are dysregulated. In an in vitro model meant to mimic a pro-inflammatory environment, stimulation of macrophages with the bacterial cell membrane component lipopolysaccharide (LPS) causes a heightened pro-inflammatory response. We have evidence that this pro-inflammatory shift is accompanied by a dramatic shift toward glycolytic metabolism. Importantly, given the metabolic and phenotypic switch, an acute infection may be a context in which the inhibition of choline metabolism could benefit host survival. Current findings suggest that choline metabolism inhibition can skew the immune population in vivo. The drug RSM-932a (RSM) inhibits the first step in the metabolism of choline toward phospholipid and causes a significant increase in pro-inflammatory markers. These findings suggest that choline inhibition could help skew an in-vivo response that would increase survival during acute bacterial infection. This proposal aims to test the hypothesis that the inhibition of choline metabolism and the subsequent pro-inflammatory immune response will increase survival outcomes in models of acute bacterial infection. We hypothesize that choline inhibition affects pro-inflammatory outputs and markers by reprogramming metabolic energy pathways. The goals of this study are to uncover if and understand how the inhibition of choline metabolism can increase survival in the face of a bacterial challenge.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Ilijevska, Maja
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~